Treatment of squamous cell carcinoma of the mobile tongue or tongue margins: An interdisciplinary challenge

References

• Howell RE, Wright BA, Dewar R. Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:205–12.
   Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
   PubMed Web of Science ®Google Scholar
• Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden. Swed Dent J Suppl 2005:1–66.
   PubMedGoogle Scholar
• Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–75.
   PubMed Web of Science ®Google Scholar
• Barry CP, Katre C, Papa E, Brown JS, Shaw RJ, Bekiroglu F, et al. De-escalation of surgery for early oral cancer – is it oncologically safe?Br J Oral Maxillofac Surg Epub 2012 Mar 21.
   Google Scholar
• Petera J, Matula P, Paluska P, Sirak I, Macingova Z, Kasaova L, et al. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma – a radiobiological study. Neoplasma 2009;56:163–8.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Karasawa K, Komiya Y, Hanyu N, Okamoto M, Chang T-C, et al. Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation. Anticancer Res 2007;27:1689–92.
   PubMed Web of Science ®Google Scholar
• Yuen AP-W, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW-M, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009;31:765–72.
   PubMed Web of Science ®Google Scholar
• Lim YC, Lee JS, Koo BS, Kim S-H, Kim Y-H, Choi EC. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: Elective neck dissection versus observation. Laryngoscope 2006;116:461–5.
   PubMed Web of Science ®Google Scholar
• D’Cruz AK, Siddachari RC, Walvekar RR, Pantvaidya GH, Chaukar DA, Deshpande MS, et al. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial. Head Neck 2009;31:618–24.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Fuwa N, Kamata M, Matsumoto A, Nakamura PK, Nakamura T, et al. Stage I and II mobile tongue carcinomas treated by external radiation and gold seed implantation. Acta Oncol 2003;42:763–70.
   PubMed Web of Science ®Google Scholar
• Lapeyre M, Bollet MA, Racadot S, Geoffrois L, Kaminsky M-C, Hoffstetter S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004;26: 216–23.
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: A case series. Head Neck 2005;27:748–56.
   PubMed Web of Science ®Google Scholar
• Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC, et al. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol 2010;5:43.
   PubMed Web of Science ®Google Scholar
• Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. Early stage carcinoma of oral tongue: Prognostic factors for local control and survival. Oral Oncol 2000;36:508–14.
   PubMed Web of Science ®Google Scholar
• El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A, et al. Squamous cell carcinoma of the oral tongue: An analysis of prognostic factors. Br J Oral Maxillofac Surg 2000;38:193–9.
   PubMed Web of Science ®Google Scholar
• Rusthoven K, Ballonoff A, Raben D, Chen C. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 2008;112:345–51.
   PubMed Web of Science ®Google Scholar
• Rusthoven KE, Raben D, Song JI, Kane M, Altoos TA, Chen C. Survival and patterns of relapse in patients with oral tongue cancer. J Oral Maxillofac Surg 2010;68:584–9.
   PubMed Web of Science ®Google Scholar
• Goldstein DP, Bachar GY, Lea J, Shrime MG, Patel RS, Gullane PJ, et al. Outcomes of squamous cell cancer of the oral tongue managed at the Princess Margaret Hospital. Head Neck 2012;5:797–803.
   Google Scholar
• Daly ME, Le Q-T, Kozak MM, Maxim PG, Murphy JD, Hsu A, et al. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: Patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys 2011;80:1412–22.
   PubMed Web of Science ®Google Scholar
• Jeanneret-Sozzi W, Moeckli R, Valley J-F, Zouhair A, Ozsahin EM, Mirimanoff R-O. The reasons for discrepancies in target volume delineation: A SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol 2006;182:450–7.
   PubMed Web of Science ®Google Scholar
• Damast S, Wolden S, Lee N. Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer. Head Neck 2012;34:900–6.
   PubMed Web of Science ®Google Scholar